Atomistry » Zinc » PDB 5vmz-5vuq » 5vse
Atomistry »
  Zinc »
    PDB 5vmz-5vuq »
      5vse »

Zinc in PDB 5vse: Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine

Enzymatic activity of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine

All present enzymatic activity of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine:
2.1.1.43;

Protein crystallography data

The structure of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine, PDB code: 5vse was solved by N.Babault, Y.Xiong, J.Liu, J.Jin, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.88 / 1.60
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 56.491, 78.691, 72.610, 90.00, 91.35, 90.00
R / Rfree (%) 16.8 / 19.1

Zinc Binding Sites:

The binding sites of Zinc atom in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine (pdb code 5vse). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 8 binding sites of Zinc where determined in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine, PDB code: 5vse:
Jump to Zinc binding site number: 1; 2; 3; 4; 5; 6; 7; 8;

Zinc binding site 1 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 1 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1501

b:24.9
occ:1.00
 SG A:CYS1027 2.3 25.2 1.0
SG A:CYS980 2.3 28.2 1.0
SG A:CYS1023 2.3 24.9 1.0
SG A:CYS1017 2.4 23.4 1.0
CB A:CYS1017 3.2 23.7 1.0
CB A:CYS1023 3.2 28.0 1.0
CB A:CYS1027 3.2 27.2 1.0
CB A:CYS980 3.3 31.4 1.0
ZN A:ZN1502 3.8 27.2 1.0
ZN A:ZN1503 3.8 27.7 1.0
SG A:CYS974 4.1 26.6 1.0
NH2 A:ARG1030 4.4 31.6 1.0
NE A:ARG1030 4.4 29.6 1.0
CB A:ASN1029 4.5 25.7 1.0
CA A:CYS1023 4.6 28.1 1.0
CA A:CYS1017 4.6 19.5 1.0
CA A:CYS1027 4.7 25.4 1.0
CA A:CYS980 4.7 31.2 1.0
O A:TRP1024 4.8 30.4 1.0
CZ A:ARG1030 4.8 28.2 1.0
N A:ASN1029 4.9 27.1 1.0
CB A:CYS1021 5.0 27.3 1.0

Zinc binding site 2 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 2 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1502

b:27.2
occ:1.00
 SG A:CYS1017 2.3 23.4 1.0
SG A:CYS987 2.3 44.6 1.0
SG A:CYS1021 2.3 25.3 1.0
SG A:CYS974 2.4 26.6 1.0
CB A:CYS1017 3.2 23.7 1.0
CB A:CYS974 3.2 33.5 1.0
CB A:CYS1021 3.3 27.3 1.0
CB A:CYS987 3.4 44.4 1.0
CA A:CYS1017 3.6 19.5 1.0
N A:CYS974 3.6 28.8 1.0
ZN A:ZN1503 3.8 27.7 1.0
ZN A:ZN1501 3.8 24.9 1.0
CA A:CYS974 3.9 26.6 1.0
SG A:CYS1023 4.1 24.9 1.0
SG A:CYS985 4.3 35.4 1.0
N A:CYS1017 4.4 23.9 1.0
CA A:CYS1021 4.6 26.1 1.0
C A:HIS973 4.6 29.0 1.0
N A:ASN1018 4.6 23.5 1.0
C A:CYS1017 4.7 24.4 1.0
CA A:CYS987 4.7 50.3 1.0
SG A:CYS980 4.7 28.2 1.0
N A:CYS987 4.7 50.4 1.0
C A:CYS974 4.8 32.4 1.0
CA A:HIS973 4.8 26.9 1.0
O A:HOH1714 4.9 40.6 1.0
O A:CYS974 4.9 28.9 1.0
ND2 A:ASN1029 4.9 26.7 1.0

Zinc binding site 3 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 3 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 3 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1503

b:27.7
occ:1.00
 SG A:CYS976 2.2 28.4 1.0
SG A:CYS974 2.4 26.6 1.0
SG A:CYS985 2.4 35.4 1.0
SG A:CYS980 2.5 28.2 1.0
CB A:CYS974 3.1 33.5 1.0
CB A:CYS976 3.1 28.3 1.0
CB A:CYS985 3.3 40.0 1.0
CB A:CYS980 3.3 31.4 1.0
ZN A:ZN1502 3.8 27.2 1.0
ZN A:ZN1501 3.8 24.9 1.0
CA A:CYS985 3.9 40.7 1.0
CA A:CYS980 3.9 31.2 1.0
SG A:CYS1017 4.1 23.4 1.0
N A:CYS976 4.3 29.0 1.0
CA A:CYS976 4.4 30.4 1.0
CA A:CYS974 4.6 26.6 1.0
O A:HOH1616 4.6 29.0 1.0
C A:CYS985 4.7 43.5 1.0
SG A:CYS1023 4.8 24.9 1.0
N A:CYS980 4.8 32.9 1.0
N A:LEU986 4.8 59.9 1.0
CB A:CYS1023 4.9 28.0 1.0
O A:HOH1717 4.9 39.1 1.0
O A:HOH1724 5.0 51.7 1.0
SG A:CYS987 5.0 44.6 1.0

Zinc binding site 4 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 4 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 4 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1504

b:33.5
occ:1.00
 SG A:CYS1175 2.2 38.1 1.0
SG A:CYS1170 2.3 37.8 1.0
SG A:CYS1168 2.3 36.6 1.0
SG A:CYS1115 2.5 38.4 1.0
CB A:CYS1175 3.0 46.3 1.0
CB A:CYS1168 3.3 36.9 1.0
CB A:CYS1170 3.3 40.4 1.0
CB A:CYS1115 3.3 42.5 1.0
CA A:CYS1175 3.6 48.1 1.0
O A:HOH1707 4.0 35.3 1.0
N A:CYS1170 4.0 36.7 1.0
N A:CYS1115 4.1 38.4 1.0
CA A:CYS1170 4.2 41.8 1.0
N A:LYS1176 4.3 40.1 1.0
C A:CYS1175 4.3 39.9 1.0
CA A:CYS1115 4.3 41.9 1.0
N A:HIS1177 4.5 39.2 1.0
NE2 A:HIS1113 4.5 30.1 1.0
CD2 A:HIS1113 4.6 29.0 1.0
CA A:CYS1168 4.6 36.6 1.0
C A:CYS1168 4.7 36.5 1.0
N A:GLY1171 4.8 40.6 1.0
N A:CYS1175 4.8 46.5 1.0
C A:CYS1170 4.9 43.9 1.0
CB A:HIS1177 5.0 38.7 1.0
O A:CYS1168 5.0 39.6 1.0

Zinc binding site 5 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 5 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 5 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn1501

b:27.6
occ:1.00
 SG B:CYS1017 2.3 28.5 1.0
SG B:CYS1023 2.3 29.2 1.0
SG B:CYS1027 2.3 30.9 1.0
SG B:CYS980 2.4 31.0 1.0
CB B:CYS1017 3.1 26.3 1.0
CB B:CYS1023 3.2 34.3 1.0
CB B:CYS1027 3.3 30.9 1.0
CB B:CYS980 3.4 42.8 1.0
ZN B:ZN1503 3.8 29.8 1.0
ZN B:ZN1502 3.8 27.9 1.0
SG B:CYS974 4.1 28.7 1.0
NH2 B:ARG1030 4.3 33.0 1.0
NE B:ARG1030 4.4 32.2 1.0
CB B:ASN1029 4.6 25.7 1.0
CA B:CYS1017 4.6 22.4 1.0
CA B:CYS1023 4.7 31.3 1.0
CA B:CYS1027 4.7 31.3 1.0
CZ B:ARG1030 4.7 33.0 1.0
CA B:CYS980 4.8 34.6 1.0
O B:TRP1024 4.8 33.9 1.0
CB B:CYS1021 4.9 28.5 1.0

Zinc binding site 6 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 6 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 6 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn1502

b:27.9
occ:1.00
 SG B:CYS974 2.3 28.7 1.0
SG B:CYS1021 2.3 26.5 1.0
SG B:CYS987 2.3 30.8 1.0
SG B:CYS1017 2.5 28.5 1.0
CB B:CYS1017 3.2 26.3 1.0
CB B:CYS1021 3.3 28.5 1.0
CB B:CYS974 3.3 31.6 1.0
CB B:CYS987 3.5 33.1 1.0
N B:CYS974 3.6 27.6 1.0
CA B:CYS1017 3.6 22.4 1.0
ZN B:ZN1503 3.7 29.8 1.0
ZN B:ZN1501 3.8 27.6 1.0
CA B:CYS974 4.0 30.9 1.0
SG B:CYS1023 4.2 29.2 1.0
SG B:CYS985 4.3 32.1 1.0
N B:CYS1017 4.5 25.6 1.0
N B:ASN1018 4.6 23.3 1.0
CA B:CYS1021 4.6 27.4 1.0
C B:HIS973 4.6 36.7 1.0
SG B:CYS980 4.6 31.0 1.0
C B:CYS1017 4.7 23.8 1.0
N B:CYS987 4.7 31.4 1.0
CA B:CYS987 4.7 30.3 1.0
CA B:HIS973 4.8 29.4 1.0
C B:CYS974 4.9 37.3 1.0
O B:HOH1720 4.9 29.3 1.0
O B:CYS974 4.9 29.5 1.0
ND2 B:ASN1029 5.0 26.9 1.0

Zinc binding site 7 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 7 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 7 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn1503

b:29.8
occ:1.00
 SG B:CYS976 2.3 34.0 1.0
SG B:CYS980 2.3 31.0 1.0
SG B:CYS985 2.3 32.1 1.0
SG B:CYS974 2.5 28.7 1.0
CB B:CYS974 3.1 31.6 1.0
CB B:CYS976 3.1 41.6 1.0
CB B:CYS980 3.2 42.8 1.0
CB B:CYS985 3.2 35.6 1.0
ZN B:ZN1502 3.7 27.9 1.0
ZN B:ZN1501 3.8 27.6 1.0
CA B:CYS985 3.8 34.7 1.0
CA B:CYS980 3.9 34.6 1.0
SG B:CYS1017 4.0 28.5 1.0
N B:CYS976 4.3 37.3 1.0
CA B:CYS976 4.4 38.5 1.0
O B:HOH1616 4.4 35.2 1.0
CA B:CYS974 4.5 30.9 1.0
C B:CYS985 4.6 38.9 1.0
SG B:CYS1023 4.8 29.2 1.0
N B:CYS980 4.8 36.4 1.0
O B:HOH1696 4.8 35.9 1.0
N B:LEU986 4.8 37.8 1.0
CB B:CYS1023 4.9 34.3 1.0
SG B:CYS987 5.0 30.8 1.0
C B:CYS974 5.0 37.3 1.0

Zinc binding site 8 out of 8 in 5vse

Go back to Zinc Binding Sites List in 5vse
Zinc binding site 8 out of 8 in the Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 8 of Structure of Human G9A Set-Domain (EHMT2) in Complex with Inhibitor 17: N~2~-Cyclopentyl-6,7-Dimethoxy-N~2~-Methyl-N~4~-(1- Methylpiperidin-4-Yl)Quinazoline-2,4-Diamine within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn1504

b:33.7
occ:1.00
 SG B:CYS1175 2.2 33.9 1.0
SG B:CYS1168 2.3 32.1 1.0
SG B:CYS1170 2.4 36.5 1.0
SG B:CYS1115 2.4 37.8 1.0
CB B:CYS1175 3.1 39.1 1.0
CB B:CYS1168 3.3 31.9 1.0
CB B:CYS1115 3.4 36.5 1.0
CB B:CYS1170 3.4 38.7 1.0
CA B:CYS1175 3.7 39.1 1.0
N B:CYS1115 4.1 33.7 1.0
N B:CYS1170 4.1 33.6 1.0
O B:HOH1744 4.1 37.9 1.0
CA B:CYS1115 4.3 34.2 1.0
CA B:CYS1170 4.3 41.0 1.0
N B:LYS1176 4.4 40.8 1.0
C B:CYS1175 4.4 42.1 1.0
CD2 B:HIS1113 4.5 27.6 1.0
NE2 B:HIS1113 4.5 29.1 1.0
N B:HIS1177 4.5 34.1 1.0
CA B:CYS1168 4.6 34.5 1.0
C B:CYS1168 4.7 38.5 1.0
CB B:HIS1177 4.9 33.0 1.0
N B:GLY1171 4.9 39.5 1.0
N B:CYS1175 4.9 47.0 1.0
N B:SER1178 5.0 34.3 1.0
O B:CYS1168 5.0 40.4 1.0
C B:CYS1170 5.0 44.0 1.0

Reference:

Y.Xiong, F.Li, N.Babault, H.Wu, A.Dong, H.Zeng, X.Chen, C.H.Arrowsmith, P.J.Brown, J.Liu, M.Vedadi, J.Jin. Structure-Activity Relationship Studies of G9A-Like Protein (Glp) Inhibitors. Bioorg. Med. Chem. V. 25 4414 2017.
ISSN: ESSN 1464-3391
PubMed: 28662962
DOI: 10.1016/J.BMC.2017.06.021
Page generated: Mon Oct 28 13:21:03 2024

Last articles

Mg in 4PB4
Mg in 4P9R
Mg in 4PAL
Mg in 4PAQ
Mg in 4PAO
Mg in 4OX9
Mg in 4P8R
Mg in 4P7A
Mg in 4P5J
Mg in 4P3E
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy